BioHarvest Says Olive Cell Asset Is Ready for Commercial Production

The company says the Botanical Synthesis-developed asset has completed development, commercial-scale manufacturing and the applicable self-affirmed GRAS process. It is ready for production at BioHarvest's GMP facility.